Isabel Lastres‐Becker

5.4k total citations
63 papers, 4.3k citations indexed

About

Isabel Lastres‐Becker is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Isabel Lastres‐Becker has authored 63 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 30 papers in Cellular and Molecular Neuroscience and 25 papers in Pharmacology. Recurrent topics in Isabel Lastres‐Becker's work include Cannabis and Cannabinoid Research (23 papers), Genomics, phytochemicals, and oxidative stress (17 papers) and Genetic Neurodegenerative Diseases (16 papers). Isabel Lastres‐Becker is often cited by papers focused on Cannabis and Cannabinoid Research (23 papers), Genomics, phytochemicals, and oxidative stress (17 papers) and Genetic Neurodegenerative Diseases (16 papers). Isabel Lastres‐Becker collaborates with scholars based in Spain, Germany and United States. Isabel Lastres‐Becker's co-authors include Javier Fernández‐Ruíz, Antonio Cuadrado, J.A. Ramos, Sebastian Kügler, Georg Auburger, Alberto Rábano, Nadia G. Innamorato, Ángel J. García‐Yagüe, Raphael Mechoulam and Rosario de Miguel and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Isabel Lastres‐Becker

61 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Lastres‐Becker Spain 37 2.0k 1.7k 1.7k 773 570 63 4.3k
Shoei Furukawa Japan 39 1.9k 1.0× 1.2k 0.7× 1.8k 1.1× 297 0.4× 510 0.9× 168 5.0k
Anke Witting Germany 22 928 0.5× 1.3k 0.7× 565 0.3× 481 0.6× 557 1.0× 25 2.5k
Meliha Karsak Germany 16 890 0.4× 1.7k 1.0× 945 0.6× 632 0.8× 288 0.5× 30 3.6k
Emmanuel Hermans Belgium 34 2.5k 1.3× 721 0.4× 2.0k 1.2× 433 0.6× 476 0.8× 149 4.3k
Takeshi Kihara Japan 40 1.3k 0.7× 790 0.5× 1.7k 1.0× 593 0.8× 791 1.4× 80 4.4k
Francisco Molina‐Holgado United Kingdom 33 1.2k 0.6× 1.9k 1.1× 487 0.3× 201 0.3× 440 0.8× 47 3.3k
Marcello D’Amelio Italy 39 1.2k 0.6× 491 0.3× 1.9k 1.1× 407 0.5× 737 1.3× 90 4.7k
Rosa M. Tolón Spain 28 1.7k 0.8× 2.4k 1.4× 605 0.4× 176 0.2× 313 0.5× 52 3.3k
Byung Kwan Jin South Korea 40 1.2k 0.6× 484 0.3× 1.4k 0.8× 814 1.1× 1.4k 2.5× 91 4.1k
Yoshiko Furukawa Japan 36 1.5k 0.7× 380 0.2× 1.3k 0.8× 532 0.7× 790 1.4× 193 4.2k

Countries citing papers authored by Isabel Lastres‐Becker

Since Specialization
Citations

This map shows the geographic impact of Isabel Lastres‐Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Lastres‐Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Lastres‐Becker more than expected).

Fields of papers citing papers by Isabel Lastres‐Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Lastres‐Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Lastres‐Becker. The network helps show where Isabel Lastres‐Becker may publish in the future.

Co-authorship network of co-authors of Isabel Lastres‐Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Lastres‐Becker. A scholar is included among the top collaborators of Isabel Lastres‐Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Lastres‐Becker. Isabel Lastres‐Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez‐Cueto, Carmen, et al.. (2024). Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia. Antioxidants. 13(9). 1072–1072. 1 indexed citations
2.
Shin, Chang Hoon, et al.. (2023). The Transcription Factor NRF2 Has Epigenetic Regulatory Functions Modulating HDACs, DNMTs, and miRNA Biogenesis. Antioxidants. 12(3). 641–641. 19 indexed citations
3.
Wells, Geoffrey, Ángeles Martín‐Requero, Ana Martı́nez, et al.. (2022). Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis. Journal of Medicinal Chemistry. 65(3). 1867–1882. 17 indexed citations
4.
Lastres‐Becker, Isabel, Marina Arribas-Blázquez, Inés Maestro, et al.. (2021). Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy. International Journal of Molecular Sciences. 22(6). 3007–3007. 22 indexed citations
5.
Galán-Ganga, Marcos, Carmen Rodríguez‐Cueto, Félix Hernández, et al.. (2021). Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration. Acta Neuropathologica Communications. 9(1). 90–90. 28 indexed citations
6.
García‐Yagüe, Ángel J., Isabel Lastres‐Becker, Leonidas Stefanis, Demetrios K. Vassilatis, & Antonio Cuadrado. (2021). α-Synuclein Induces the GSK-3-Mediated Phosphorylation and Degradation of NURR1 and Loss of Dopaminergic Hallmarks. Molecular Neurobiology. 58(12). 6697–6711. 15 indexed citations
7.
Robledinos-Antón, Natalia, et al.. (2019). NRF2-dependent gene expression promotes ciliogenesis and Hedgehog signaling. Scientific Reports. 9(1). 13896–13896. 16 indexed citations
8.
García‐Yagüe, Ángel J., et al.. (2019). CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: Implications in tauopathies. Redox Biology. 22. 101118–101118. 54 indexed citations
9.
Lastres‐Becker, Isabel, David Nonis, Joachim Nowock, & Georg Auburger. (2019). New alternative splicing variants of the ATXN2 transcript. SHILAP Revista de lepidopterología. 1(1). 22–22. 12 indexed citations
10.
Lastres‐Becker, Isabel, Ángel J. García‐Yagüe, Robert H. Scannevin, et al.. (2016). Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease. Antioxidants and Redox Signaling. 25(2). 61–77. 227 indexed citations
11.
Lastres‐Becker, Isabel, Nadia G. Innamorato, Tomasz Jaworski, et al.. (2013). Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Brain. 137(1). 78–91. 131 indexed citations
12.
Niso‐Santano, Mireia, Rosa A. González‐Polo, José Manuel Bravo‐San Pedro, et al.. (2010). Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: Modulation by the Nrf2/Trx axis. Free Radical Biology and Medicine. 48(10). 1370–1381. 111 indexed citations
13.
Lastres‐Becker, Isabel, Susanne Brodesser, Dieter Lütjohann, et al.. (2008). Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Human Molecular Genetics. 17(10). 1465–1481. 104 indexed citations
14.
Lastres‐Becker, Isabel, Francisco Molina‐Holgado, J.A. Ramos, Raphael Mechoulam, & Javier Fernández‐Ruíz. (2005). Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease. Neurobiology of Disease. 19(1-2). 96–107. 323 indexed citations
15.
Lago, Eva de, Rosario de Miguel, Isabel Lastres‐Becker, J.A. Ramos, & Javier Fernández‐Ruíz. (2004). Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. Brain Research. 1007(1-2). 152–159. 78 indexed citations
16.
Lastres‐Becker, Isabel, Nicolas Bizat, Frédéric Boyer, et al.. (2004). Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo. Neuroreport. 15(15). 2375–2379. 48 indexed citations
17.
Lastres‐Becker, Isabel, Nicolas Bizat, Frédéric Boyer, et al.. (2003). Effects of cannabinoids in the rat model of Huntington’s disease generated by an intrastriatal injection of malonate. Neuroreport. 14(6). 813–816. 52 indexed citations
18.
Lastres‐Becker, Isabel, Henrik H. Hansen, Fernando Berrendero, et al.. (2002). Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. Synapse. 44(1). 23–35. 95 indexed citations
19.
Lastres‐Becker, Isabel, María Gómez‐Ruíz, Rosario de Miguel, J.A. Ramos, & Javier Fernández‐Ruíz. (2002). Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington’s disease. Neurotoxicity Research. 4(7-8). 601–608. 22 indexed citations
20.
Hansen, Henrik H., Patricia C. Schmid, Petra Bittigau, et al.. (2001). Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration. Journal of Neurochemistry. 78(6). 1415–1427. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoei Furukawa Breakdown of academic impact, for papers by Anke Witting Breakdown of academic impact, for papers by Meliha Karsak Breakdown of academic impact, for papers by Emmanuel Hermans Breakdown of academic impact, for papers by Takeshi Kihara Breakdown of academic impact, for papers by Francisco Molina‐Holgado Breakdown of academic impact, for papers by Marcello D’Amelio Breakdown of academic impact, for papers by Rosa M. Tolón Breakdown of academic impact, for papers by Byung Kwan Jin Breakdown of academic impact, for papers by Yoshiko Furukawa
Rankless by CCL
2026